期刊
ADVANCES IN MEDICAL SCIENCES
卷 67, 期 1, 页码 79-86出版社
ELSEVIER URBAN & PARTNER SP Z O O
DOI: 10.1016/j.advms.2021.12.003
关键词
Polycystic ovary syndrome; Hyperprolactinemia; Upper reference limit; Quantile regression; Luteinizing hormone
资金
- Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Iran [24977-ERC-2020]
This study aimed to explore the upper reference limit of prolactin (PRL) in women with polycystic ovary syndrome (PCOS). The results showed that in PCOS women under the age of 35, the upper reference limit of serum PRL was approximately 1.5-fold higher than in controls. The elevation of PRL in PCOS might be attributed to a decline in central dopaminergic tone associated with PCOS, leading to an increase in levels of both PRL and luteinizing hormone (LH).
Purpose: Polycystic ovary syndrome (PCOS) and hyperprolactinemia are the most frequent endocrine disorders in women which share several common features. There are inconsistent results regarding the existence of a possible pathophysiological interplay between these endocrinopathies and the elevation of prolactin (PRL) in PCOS. The purpose of this study was to explore the upper reference limit of PRL in PCOS women. Patients and methods: This study is a cross-sectional analysis using data collected from two population-based PCOS prevalence studies. After considering the exclusion criteria, 216 women with PCOS diagnosed based on the Rotterdam criteria and 702 eumenorrheic non-hirsute controls, were enrolled. The age distribution of PRL and the effect of PCOS on the percentiles of serum PRL were compared between the PCOS group and controls. The possible contributing factors for the elevation of PRL were evaluated. Results: In the subgroup of women with PCOS, aged <35 years, the age-adjusted model of quantile regression revealed a significant elevation of PRL from the 60th percentile onwards, leading to an increase of nearly 10 ng/ ml (p 1/4 0.023, 95% CI 1.3-17.62) of the 95th percentile of PRL. Hyperprolactinemic PCOS women had higher levels of luteinizing hormone (LH). Conclusions: In PCOS women, aged <35 years, the upper reference limit of serum PRL was approximately 1.5-fold higher than in controls. The pathway underlying PRL elevation in PCOS might be attributed to a decline in central dopaminergic tone associated with PCOS which leads to an increase in levels of both - PRL and LH.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据